What is Dyne Therapeutics, Inc. Common Stock's Market Cap?

Dyne Therapeutics, Inc. Common Stock's Market Cap is $3.8B, based on as-reported figures from SEC (XBRL) filings.

What is Dyne Therapeutics, Inc. Common Stock's Enterprise Value?

Dyne Therapeutics, Inc. Common Stock's Enterprise Value is $3.3B, based on as-reported figures from SEC (XBRL) filings.

What is Dyne Therapeutics, Inc. Common Stock's EV / EBITDA?

Dyne Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Dyne Therapeutics, Inc. Common Stock's Net Income (TTM)?

Dyne Therapeutics, Inc. Common Stock's Net Income (TTM) is -$519.4M, based on as-reported figures from SEC (XBRL) filings.

What is Dyne Therapeutics, Inc. Common Stock's EBITDA?

Dyne Therapeutics, Inc. Common Stock's EBITDA is -$534.8M, based on as-reported figures from SEC (XBRL) filings.

What is Dyne Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Dyne Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.78, based on as-reported figures from SEC (XBRL) filings.

What is Dyne Therapeutics, Inc. Common Stock's Net Debt?

Dyne Therapeutics, Inc. Common Stock's Net Debt is -$476.8M, based on as-reported figures from SEC (XBRL) filings.

Dyne Therapeutics, Inc. Common Stock (DYN) Financial Statements

Dyne Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00NSGPJF8

XNAS · usd

20.31▼ 3.97 (-16.35%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close24.28

Day's Range17.00 – 20.91

52-Week Range11.92 – 27.31

Volume17.0M

Avg Volume2.3M

Share Statistics

Shares Outstanding

Employees258

ExchangeXNAS

Listed2020-09-17

Share count as of July 24, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Dyne Therapeutics, Inc. Common Stock (DYN)

What is Dyne Therapeutics, Inc. Common Stock's Market Cap?: Dyne Therapeutics, Inc. Common Stock's Market Cap is $3.8B, based on as-reported figures from SEC (XBRL) filings.
What is Dyne Therapeutics, Inc. Common Stock's Enterprise Value?: Dyne Therapeutics, Inc. Common Stock's Enterprise Value is $3.3B, based on as-reported figures from SEC (XBRL) filings.
What is Dyne Therapeutics, Inc. Common Stock's EV / EBITDA?: Dyne Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Dyne Therapeutics, Inc. Common Stock's Net Income (TTM)?: Dyne Therapeutics, Inc. Common Stock's Net Income (TTM) is -$519.4M, based on as-reported figures from SEC (XBRL) filings.
What is Dyne Therapeutics, Inc. Common Stock's EBITDA?: Dyne Therapeutics, Inc. Common Stock's EBITDA is -$534.8M, based on as-reported figures from SEC (XBRL) filings.
What is Dyne Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Dyne Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.78, based on as-reported figures from SEC (XBRL) filings.
What is Dyne Therapeutics, Inc. Common Stock's Net Debt?: Dyne Therapeutics, Inc. Common Stock's Net Debt is -$476.8M, based on as-reported figures from SEC (XBRL) filings.